- Home
- ASTI vs ADXN Comparison
ASTI vs ADXN Comparison
Compare ASTI & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- ADXN
- Stock Information
- Founded
- ASTI 2005
- ADXN 2002
- Country
- ASTI United States
- ADXN Switzerland
- Employees
- ASTI N/A
- ADXN 2
- Industry
- ASTI Semiconductors
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- ADXN Health Care
- Exchange
- ASTI Nasdaq
- ADXN Nasdaq
- Market Cap
- ASTI 6.7M
- ADXN 7.9M
- IPO Year
- ASTI N/A
- ADXN N/A
- Fundamental
- Price
- ASTI $1.67
- ADXN $8.47
- Analyst Decision
- ASTI
- ADXN
- Analyst Count
- ASTI 0
- ADXN 0
- Target Price
- ASTI N/A
- ADXN N/A
- AVG Volume (30 Days)
- ASTI 571.3K
- ADXN 8.0K
- Earning Date
- ASTI 11-10-2025
- ADXN 11-10-2025
- Dividend Yield
- ASTI N/A
- ADXN N/A
- EPS Growth
- ASTI N/A
- ADXN N/A
- EPS
- ASTI N/A
- ADXN N/A
- Revenue
- ASTI $61,134.00
- ADXN $210,347.00
- Revenue This Year
- ASTI N/A
- ADXN $86.57
- Revenue Next Year
- ASTI N/A
- ADXN N/A
- P/E Ratio
- ASTI N/A
- ADXN N/A
- Revenue Growth
- ASTI 36.85
- ADXN N/A
- 52 Week Low
- ASTI $1.10
- ADXN $6.51
- 52 Week High
- ASTI $4.41
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- ASTI 37.63
- ADXN 44.99
- Support Level
- ASTI $1.58
- ADXN $8.54
- Resistance Level
- ASTI $1.75
- ADXN $9.42
- Average True Range (ATR)
- ASTI 0.18
- ADXN 0.44
- MACD
- ASTI -0.04
- ADXN -0.08
- Stochastic Oscillator
- ASTI 28.75
- ADXN 3.52
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.